MOLECULIN BIOTECH INC (MBRX) Stock Analyst Ratings
USA - NASDAQ:MBRX - US60855D3098 - Common Stock
0.4876 USD
+0.01 (+1.82%)
0.48 USD
-0.01 (-1.56%)
ChartMill assigns a Buy % Consensus number of 82% to MBRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.8. This target is 1294.59% above the current price.
MBRX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MBRX.
In the previous month the buy percentage consensus was at a similar level.
MBRX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-25 | Maxim Group | Upgrade | Hold -> Buy |
| 2025-03-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-12 | Maxim Group | Maintains | Buy -> Buy |
| 2024-04-12 | Roth MKM | Maintains | Buy -> Buy |
| 2024-03-26 | Maxim Group | Maintains | Buy -> Buy |
| 2023-12-14 | HC Wainwright & Co. | Initiate | Buy |
| 2023-04-18 | Roth MKM | Maintains | Buy |
| 2023-03-24 | Oppenheimer | Reiterate | Outperform |
MOLECULIN BIOTECH INC / MBRX FAQ
Can you provide the average price target for MOLECULIN BIOTECH INC stock?
9 analysts have analysed MBRX and the average price target is 6.8 USD. This implies a price increase of 1294.59% is expected in the next year compared to the current price of 0.4876.
What is the consensus rating for MOLECULIN BIOTECH INC (MBRX) stock?
The consensus rating for MOLECULIN BIOTECH INC (MBRX) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.